Original CommunicationsA Systematic Review of Barriers and Interventions to Improve Appropriate Use of Therapies for Sickle Cell Disease
REFERENCES (68)
- et al.
Sickle cell-related pain: perceptions of medical practitioners
J Pain Symptom Manage.
(1997) Does blinding of readers affect the results of meta-analyses? University of Pennsylvania Meta-analysis Blinding Study Group
Lancet
(1997)- et al.
Assessing the quality of reports of randomized clinical trials: is blinding necessary?
Control Clin Trials
(1996) - et al.
Optimism Predicting Daily Pain Medication Use in Adolescents with Sickle Cell Disease
J. Pain Symptom Manage.
(2007) - et al.
A natural history study of adolescents and young adults with sickle cell disease as they transfer to adult care: a need for case management services
J Pediatr Nurs
(2002) - et al.
Nurses’ attitudes and practices in sickle cell pain management
Appl Nurs Res
(2001) - et al.
Does a clinical pathway improve the quality of care for sickle cell anemia?
Jt Comm J Qual Saf
(2003) - et al.
Improving adherence with deferoxamine regimens for patients receiving chronic transfusion therapy
Semin Hematol
(2001) The 59th World Health Assembly
- et al.
Inherited Disorders of Hemoglobin
Mortality in sickle cell disease. Life expectancy and risk factors for early death
N Engl J Med
Screening for Hemoglobinopathies US Preventive Services Task Force, Guidelines from Guide to Clinical Preventive Services
Health related quality of life in sickle cell patients: the PiSCES project
Health Qual Life Outcomes.
Department of Health and Human Services: National Heart, Lung, and Blood Institute
Understanding pain and improving management of sickle cell disease: the PiSCES study
J Natl Med Assoc
Geographic differences in mortality of young children with sickle cell disease in the United States
Public Health Rep
Provision of pneumococcal prophylaxis for publicly insured children with sickle cell disease
JAMA
Hospitalization rates and costs of care of patients with sickle-cell anemia in the state of Maryland in the era of hydroxyurea
Am J Hematol
How much do sample characteristics affect the effect size? An investigation of studies testing the treatment effects for social phobia
J Anxiety Disord.
Methodological rigour within a qualitative framework
J Adv Nurs
Evaluation of qualitative research
J Clin Nurs
Grading quality of evidence and strength of recommendations
BMJ
Therapy preference and decision-making among patients with severe sickle cell anemia and their families&
Pediatr Blood Cancer
Barriers to adherence of deferoxamine usage in sickle cell disease
Pediatr Blood Cancer
Physician knowledge and adherence to prescribing antibiotic prophylaxis for sickle cell disease
Int J Qual Health Care
Parental health beliefs and compliance with prophylactic penicillin administration in children with sickle cell disease
J Pediatr Hematol Oncol
Compliance with penicillin prophylaxis in patients with sickle cell disease
Arch Pediatr Adolesc Med
Caregiver knowledge and adherence in children with sickle cell disease: Knowing is not doing
J. Clin Psychol Med Settings.
Impact of children’s sickle cell history on nurse and physician ratings of pain and medication decisions
J Pediatr Psychol
Rural/urban differences in access to and utilization of services among people in Alabama with sickle cell disease
Public Health Rep
Parent factors and adolescent sickle cell disease: associations with patterns of health service use
J Pediatr Psychol
Cited by (108)
Structural Racism and Impact on Sickle Cell Disease: Sickle Cell Lives Matter
2022, Hematology/Oncology Clinics of North AmericaCitation Excerpt :It is no wonder that prescription of life-saving HU for SCD,43,44 though it is cost-effective45,46 and has been declared a public good,47,48 is far below what is appropriate.49–51 When HU is offered or prescribed, it may not be accepted or may not be taken regularly.52 Patients may refuse HU, thinking it won’t work.53,54
The Bias of Medicine in Sickle Cell Disease
2023, Journal of General Internal Medicine
Funding/Support: This project was funded under contract 290-02-0018 from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services. Mr Haywood’s effort was supported by a National Research Service Award from the National Heart, Lung, and Blood Institute (5F31HL082037-03). Dr Beach’s effort was supported by K08-HS13903 from AHRQ.
Disclaimer: The authors of this report are responsible for its content. Statements in the report should not be construed as endorsement by AHRQ; the National Heart, Lung, & Blood Institute; or the US Department of Health and Human Services.